Member Info for Laura2022

Yes

Large buys in background

Think first offer will be reported before 20th Feb deadline

Bidding 0 29p for 4mln

Yet ask side

£2k 0 339

£3k 0.349

£5k NT

In TRT recent (3yr history)

As it only has 15mln shares it will be exacerbated volatility, see 90p+ as target in Q1

Loading up while cheap, the 68p stock gone now

Max to buy is now down to just £7k

Ree rate once 12p goes on 5yr chart

1.55/1.6

Also announced these 23rd Dec

Physiomics plc (AIM: PYC), announces an award of share options (the "Options") over ordinary shares of 0.4 pence each in the capital of the Company ("Ordinary Shares"). The Company considers that it is important to incentivise its key employees to create shareholder value and, as such, today the Board has approved the award of the following options to Mr Jesse Thissen, Head of Biometrics, under the Company's existing share option scheme (the "Scheme"):

1. 1,516,044 Options with an exercise price of 0.41 pence, representing a 41% premium to the closing mid-market price per Ordinary Share on 22 December 2025. All these Options vest on the first anniversary of Mr Thissen's employment, being 1 July 2026.

2. 1,516,044 Options with exercise price of 0.79 pence, representing a 172% premium to the closing mid-market price per Ordinary Share on 22 December 2025. One third of these Options vest on each anniversary of Mr Thissen's employment (33.3% from 1 July 2026, 66.7% from 1 July 2027 and 100% from 1 July 2028)

3. 1,516,044 Options with an exercise price of 1.29 pence, representing a 345% premium to the closing mid-market price per Ordinary Share on 22 December 2025. These Options vest over the same time periods as described under (2) above.

Nt to buy £4k/5k

Very unusual given the large sells 10 days ago

Looks ready to break range

GDP is paying dividends and could be throwing off £5mln-10mlm of free cash flow 2026 !

Beijing’s dominance of rare earths crucial to industries from automotive to electronics has sparked a rush among buyers to source the metals elsewhere, with more than 30 projects set for production this decade.

There are 33 “advanced” projects on track to start operating

in parts of the world including Europe, Africa and Australia within five years, according to Adamas Intelligence. The advisory firm, which tracks more than 300 rare earths projects globally, said there was a “large influx of public and private funding going into the rare earth space”.

China dominates the production of rare earths that go into the permanent magnets used in industries crucial to the energy transition, such as wind turbines and electric vehicles, putting the metals at the centre of trade tensions with the US. But building new mines is hugely expensive, risky and time consuming.

Brilliant

Helps REE and HMI

As expected once 14p went

TF

Strange you've had 7 posts here where you don't hold and none on GENI which you do ?

Vernet

Great summary

Seller cleared now and still a massive take over target at just £20mln cap

Thermo Fisher Scentific, to support its revenue scale-up and expansion strategy for its lead product CARDIO inCode-Score across Europe, the UK, and the United States which will assist the Company to transitioning towards break-even over the medium term.

CVD is the leading cause of death worldwide, responsible for over 17.9 million deaths annually, which equates to approximately 31% of all global deaths (World Health Organisation). With the global annual cost of CVD projected to surpass $1.04 trillion

Explains why it was NT to buy at 1.3p

Should be 2p+ very soon

After 10yrs on LSE and just on BMV TRT its best to just filter

Atb

I'm fine thanks

And expect to make profit at these levels

See you in 4yrs ;)

So you were in the rise BUT never once posted

Yeah...right :)